What Researchers Did
Researchers compared the effectiveness of hyperbaric oxygen therapy combined with steroid therapy versus steroid therapy alone in 109 patients with sudden hearing loss.
What They Found
The HBOT combination group (59 sides) exhibited a higher overall recovery rate than the HBOT noncombination group (50 sides), especially in severe cases. Lower NLR (cutoff 2.43) and PLR (cutoff 146.67) values were useful for predicting better recovery rates in patients treated with concomitant HBOT.
What This Means for Canadian Patients
Canadian patients experiencing sudden severe hearing loss might benefit from hyperbaric oxygen therapy combined with steroid treatment. Additionally, blood tests for inflammatory markers like NLR and PLR could help predict who will respond best to this combined therapy.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
The abstract does not explicitly detail the study's limitations, but potential factors include its specific patient population or single-center design.